Children's Hospital Colorado reports a 73% rise in patients who used its Eating Disorders Program over the last year.
Theravance is educating physicians and payers in anticipation of phase 3 data on ampreloxetine in nOH due to MSA. The company ...
Patients with presyncope and those with syncope in the ED have similar 30‑day serious cardiac outcomes, although patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback